WHO ICTRP trial

Evaluation of Novel Thrombolytic TGD001 in Patients With Acute Ischemic Stroke

CTIS2025-522455-26-00 · EU Clinical Trials Information System · Recruiting

Key facts

Trial ID CTIS2025-522455-26-00
Public title Evaluation of Novel Thrombolytic TGD001 in Patients With Acute Ischemic Stroke
Scientific title A Phase 1b/2a Open-Label Dose-Finding Followed by Randomized, Double-Blind, Placebo-Controlled Expansion Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of TGD001 in Patients with Acute Ischemic Stroke - TG1-CL-201
Primary sponsor TargED Biopharmaceuticals B.V.
Registry EU Clinical Trials Information System
Recruitment status Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): Yes Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No
Countries Serbia;Germany;Poland;Spain
Conditions Acute Ischemic Stroke MedDRA version: 20.0Level: SOCClassification code: 10029205Term: Nervous system disorders Class: 8 MedDRA version: 22.1Level: LLTClassification code: 10055221Term: Ischemic stroke Class: 10029205;Therapeutic area…
Interventions Product Name: SODIUM CHLORIDE SOLUTION 0.9%, Product Code:SUB20079, Pharmaceutical Form: SOLUTION FOR INFUSION, Other descriptive name: , Strength: , Pharmaceutical form of the placebo: SOLUTION FOR INFUSION , Product Name: , Product…
Registration date Sep 7, 2025
Target size 130
Registry page euclinicaltrials.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations